Trials / Completed
CompletedNCT01688193
Study to Evaluate and Compare Safety and Pharmacokinetics of the HCP1004 and VIMOVO 500/20mg in Healthy Korean Male
Randomized, Open, 2-way Cross Over, Single Dose Study to Evaluate and Compare Safety and Pharmacokinetics of the HCP1004 and VIMOVO 500/20mg in Healthy Korean Male
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 68 (actual)
- Sponsor
- Hanmi Pharmaceutical Company Limited · Industry
- Sex
- Male
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to Evaluate and Compare Safety and Pharmacokinetics of the HCP1004 and VIMOVO 500/20mg in Healthy Korean Male
Conditions
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2012-12-01
- Completion
- 2012-12-01
- First posted
- 2012-09-19
- Last updated
- 2013-01-07
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01688193. Inclusion in this directory is not an endorsement.